KRAS and non-small cell lung carcinoma: The most frequent oncogenic driver in NSCLC is the Kirsten rat sarcoma viral oncogene (KRAS), which is present in up to 40% of all cases, with the most common mutations being G12C, G12V, and G12D (6).